Literature DB >> 8241710

Heart muscle ubiquinone and plasma antioxidants following cardiac transplantation.

J Karlsson1, J Liska, S Gunnes, B Koul, B Semb, H Aström, B Diamant, K Folkers.   

Abstract

Nine patients who underwent heart transplantation (one female; average age 48 +/- 11, range 19-58 years) were followed in respect to contents of right-sided heart septum, blood and plasma ubiquinone (UQ), plasma alpha-tocopherol (alpha T), and plasma free cholesterol (FC). In contrast to healthy persons, substantial inter- and intraindividual variations were observed; individually low values were seen with rejection. Heart muscle UQ in well-treated patients averaged 0.33 +/- 0.08, range 0.06-0.58 micrograms mg-1 (0.38 +/- 0.09 mumol g-1 dry weight) and was not different from healthy individuals. Plasma UQ, alpha T; and FC averaged 0.63 +/- 0.33 micrograms ml-1 (P < 0.05 versus sedentary controls), 8.1 +/- 4.0 micrograms ml-1 (P < 0.01), and 0.52 +/- 0.23 mg ml-1 (P < 0.05). Corresponding molar values were 0.73 +/- 0.37 (UQ), 2.0 +/- 1.1 mumol l-1 (alpha T), and 1.42 +/- 0.54 mmol l-1 (FC). Blood and plasma UQ values were identical. A saturation like relationship was found between heart and blood UQ:blood contents below 0.7 micrograms ml-1 (0.8 mumol l-1) corresponded to markedly lowered heart contents. In four patients in whom blood samples were taken close to a fatal complication it averaged 0.42 micrograms ml-1 (0.49 mumol l-1, P < 0.01). When low heart muscle and blood ubiquinone were present, other variables such as left ventricle cardiac output or cycle ergometer performance was markedly impaired. Plasma UQ and alpha T covaried with a marker of the lipoidal deposit volume, plasma FC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241710     DOI: 10.1007/bf00226845

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  19 in total

1.  Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy.

Authors:  P H Langsjoen; P H Langsjoen; K Folkers
Journal:  Am J Cardiol       Date:  1990-02-15       Impact factor: 2.778

Review 2.  Lipoprotein structure and metabolism.

Authors:  R L Jackson; J D Morrisett; A M Gotto
Journal:  Physiol Rev       Date:  1976-04       Impact factor: 37.312

3.  Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions.

Authors:  K Johansen; H Theorell; J Karlsson; B Diamant; K Folkers
Journal:  Ann Med       Date:  1991-12       Impact factor: 4.709

4.  Determination of coenzyme Q10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection.

Authors:  P O Edlund
Journal:  J Chromatogr       Date:  1988-03-04

5.  Biosynthesis of ubiquinone in rat liver.

Authors:  A Kalén; E L Appelkvist; G Dallner
Journal:  Acta Chem Scand B       Date:  1987-01

6.  Lovastatin decreases coenzyme Q levels in humans.

Authors:  K Folkers; P Langsjoen; R Willis; P Richardson; L J Xia; C Q Ye; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Lovastatin decreases coenzyme Q levels in rats.

Authors:  R A Willis; K Folkers; J L Tucker; C Q Ye; L J Xia; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Free radical mediation of the effects of acidosis on calcium transport by cardiac sarcoplasmic reticulum in whole heart homogenates.

Authors:  M L Hess; E Okabe; P Ash; H A Kontos
Journal:  Cardiovasc Res       Date:  1984-03       Impact factor: 10.787

9.  Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts.

Authors:  S Vadhanavikit; M Morishita; G A Duff; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1984-09-28       Impact factor: 3.575

10.  Coenzyme Q10 content in different parts of the normal human heart.

Authors:  L Lin; P Sotonyi; E Somogyi; J Karlsson; K Folkers; Y Nara; C Sylvén; L Kaijser; E Jansson
Journal:  Clin Physiol       Date:  1988-08
View more
  2 in total

1.  Vitamins Q and E, extracorporal circulation and hemolysis.

Authors:  J Karlsson; R Ronneberg; B Semb
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Prevention of pancreatic islet xenograft rejection by dietary vitamin E.

Authors:  P Vajkoczy; H A Lehr; C Hübner; K E Arfors; M D Menger
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.